Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive health, an issue critical to gender equality and societal well-being.
I big applaud to Henriette Svarre Nielsen medical specialist, research leader in fertility and women’s health and board member of ReproUnion. Henriette shared key insights from the Reproductive Lighthouse project ReproUnion a cross-border public-private collaboration in reproductive medicine, supported by Ferring since 2015. Henriette highlighted the critical gaps in gender equality in health and the lack of understanding of female biology. Trine Bartholdy shared with a personal touch the success story of the BioInnovation Institute a cross-sector partnership and Kelle Moley introduced the important Project Family Safe Birth and how Ferring collaborates with WHO and WEF to provide women access to quality care and treatment during pregnancy and childbirth.
Key takeaways:
– Gender equality is 130 years away at the current pace due to the “black box” of women’s health.
– Women spend 25% more of their lives in poor health, significantly impacting labor force participation.
– Closing the health gap isn’t just good—it’s an economic opportunity worth trillions!
Infertility, affecting 15% of the population, is no longer a niche issue. With declining fertility rates globally, fertility is a foundation of societal health. ReproUnion is leading the way with the world’s largest Biobank and infertility cohort – RUBIC, aiming to uncover critical insights by studying couples, not just individuals.
RUBIC tackles key issues such as:
▶️ Male infertility: 3 out of 4 men in Denmark have suboptimal sperm quality.
▶️ The impact of environmental factors like endocrine disruptors on DNA quality.
▶️ Microbiota in reproductive health—pioneering work with Ferring
Henriette also shared a breath taking story of the first ever vaginal microbiome transplant helping a woman with a history of stillbirth and late pregnancy loss conceive her first child – a story of true innovation.
We’re only halfway through RUBIC’s journey and need continued support to unlock breakthroughs in both fertility and women’s health.
